GLUE - Financial Reports List - Monte Rosa Therapeutics, Inc. - IntrinsicAlpha

Monte Rosa Therapeutics, Inc. GLUE

Healthcare - Biotechnology - NASDAQ - US

$ 4.585

-1.98 %

$ 282 M

Market Cap

-4.55

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	592.95%	140.41%	137.30%
Annual Report	FY	10-K	2024-12-31	0.00%	46.29%	43.40%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	31.60%	28.24%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	13.84%	12.30%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-7.21%	-2.01%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-14.37%	-7.31%
Annual Report	FY	10-K	2023-12-31	0.00%	-29.38%	-27.52%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-32.77%	-30.34%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-36.84%	-36.69%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-26.55%	-40.97%

1